You have to ask yourself what would look more inticing to an American investor once it lists on the NASDAQ
- an Aussie biotech with not enough cash putting it's hand out and asking for money from them right out of the gate?
- or an Aussie biotech that is cashed up and funded for Phase III?
I would take the latter.
So I am not worried by the Cap raising at all. The listing and the medical milestones to come will reward all of us.
trading halt, page-24
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |